Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment.

× No keyword cloud information.

25 in total

1. Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report.

Authors: Daniel Russell Richardson; Brian Ellis; Inderjit Mehmi; Monique Leys
Journal: Int J Ophthalmol Date: 2017-07-18 Impact factor: 1.779

Review 2. Checkpoint Inhibitors.

Authors: Lucie Heinzerling; Enrico N de Toni; Georg Schett; Gheorghe Hundorfean; Lisa Zimmer
Journal: Dtsch Arztebl Int Date: 2019-02-22 Impact factor: 5.594

Review 3. Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology.

Authors: Laura C Cappelli; Ami A Shah; Clifton O Bingham
Journal: Rheum Dis Clin North Am Date: 2016-10-22 Impact factor: 2.670

Review 4. Identifying and managing the adverse effects of immune checkpoint blockade.

Authors: Arthur Winer; J Nicholas Bodor; Hossein Borghaei
Journal: J Thorac Dis Date: 2018-02 Impact factor: 2.895

5. A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema.

Authors: Jason M Redman; Logan P Rhea; Lisa Cordes; Helen Owens; Ravi A Madan; Marijo Bilusic; James L Gulley; Jung-Min Lee; William L Dahut; Fatima Karzai
Journal: Clin Genitourin Cancer Date: 2019-02-14 Impact factor: 2.872

6. SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019).

Authors: M Majem; E García-Martínez; M Martinez; E Muñoz-Couselo; D Rodriguez-Abreu; R Alvarez; A Arance; A Berrocal; L de la Cruz-Merino; J A Lopez-Martin
Journal: Clin Transl Oncol Date: 2020-01-28 Impact factor: 3.405

7. Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition.

Authors: Michel M Sun; Ralph D Levinson; Artur Filipowicz; Stephen Anesi; Henry J Kaplan; Wei Wang; Debra A Goldstein; Sapna Gangaputra; Robert T Swan; H Nida Sen; Lynn K Gordon
Journal: Ocul Immunol Inflamm Date: 2019-03-01 Impact factor: 3.070

Review 8. Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature.

Authors: Laura C Cappelli; Anna Kristina Gutierrez; Clifton O Bingham; Ami A Shah
Journal: Arthritis Care Res (Hoboken) Date: 2017-09-21 Impact factor: 4.794

9. Bilateral Uveitis and Keratitis Following Nivolumab Treatment for Metastatic Melanoma.

Authors: Douglas M Baughman; Cecilia S Lee; Brian E Snydsman; Hoon C Jung
Journal: Med Case Rep (Wilmington) Date: 2017-04-14

Review 10. Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?

Authors: Michiel van der Vlist; Jurgen Kuball; Timothy R D Radstake; Linde Meyaard
Journal: Nat Rev Rheumatol Date: 2016-08-19 Impact factor: 20.543